Banco Santander Central Hispano Aktie [WKN: 873816 / ISIN: US05964H1059]

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Historisch	Analysen

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Nachrichten zu Banco Santander Central Hispano, SAShs Sponsored American Deposit.Receipt Repr.1 Sh

28.04.20		Santander Q1 Attributable Profit Dips On COVID-19 Reserve Build (RTTNews)
03.04.20		Banco Santander Withdraws FY19 Final Dividend, Dividend Policy For 2020 (RTTNews)
24.06.19		Allianz, Banco Santander To End Bancassurance Partnership In Spain (RTTNews)
03.04.19		Banco Santander To Invest Over EUR 20 Bln In Digital And Technology Over 4 Years (RTTNews)
27.02.19		Banco Santander Says Board Intends To Set Pay-out Ratio Of 40-50% In Mid-term (RTTNews)
30.01.19		Grupo Santander FY18 Attributable Profit Rises - Quick Facts (RTTNews)
19.12.18		FCA Fines Santander GBP 32.8 Mln Over Deceased Customers' Accounts (RTTNews)
18.09.18		Banco Santander In Early Talks To Acquire Peel Hunt (RTTNews)
13.06.18		Santander Bank Raises Its Prime Rate to 5% (PR Newswire)
13.06.18		How Ameritech Financial Can Help Women and Minorities With Student Loans (PR Newswire)
13.06.18		Canadian employers underestimate the proportion of their workforce with a chronic condition and its impact (PR Newswire)
13.06.18		Canadian employers underestimate the proportion of their workforce with a chronic condition and its impact (PR Newswire)
04.06.18		New England Journal of Medicine publishes pivotal cemiplimab trials showing positive results in advanced cutaneous squamous cell carcinoma (PR Newswire)
22.05.18		Mahesh Aditya Named Chief Risk Officer of Santander Holdings USA, Inc. (PR Newswire)
22.05.18		FDA to review Zynquista™ (sotagliflozin) as potential treatment for type 1 diabetes (PR Newswire)
21.05.18		New England Journal of Medicine publishes two positive Phase 3 trials showing Dupixent® (dupilumab) improved moderate-to-severe asthma (PR Newswire)
17.05.18		Santander and Broadridge Complete a First Practical Use of Blockchain for Investor Voting at an Annual General Meeting (PR Newswire)
16.05.18		Dupixent® (dupilumab) showed positive Phase 3 results in adolescents with inadequately controlled moderate-to-severe atopic dermatitis (PR Newswire)
07.05.18		Building Safety Month Is Right Time To Assess Lightning's Dangers (PR Newswire)
04.05.18		Santander Bank Celebrates National Small Business Week by Donating Close to $1.1 Million to Leading Non-Profits Driving Small Business Development (PR Newswire)
02.05.18		DocPanel Announces Partnership with the University of Southern California Keck School of Medicine (PR Newswire)
01.05.18		Santander Universities extends partnership with Columbia Business School by providing generous financial support to two entrepreneurship programs (PR Newswire)
01.05.18		Sanofi and Regeneron to lower net price of Praluent® (alirocumab) Injection in exchange for straightforward, more affordable patient access for Express Scripts patients (PR Newswire)
30.04.18		Santander Earns an Upgraded Community Reinvestment Act (CRA) Rating from the OCC (PR Newswire)
30.04.18		FDA to Conduct Priority Review of Cemiplimab as a Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma (PR Newswire)
27.04.18		Sanofi: First-quarter 2018 Business EPS up 1.4% at CER (PR Newswire)
26.04.18		SnapAR 'Augmented Reality Video Messenger' available on the Apple App Store (PR Newswire)
25.04.18		Santander Bank Wins Internet Advertising Award for its Business Banking Microsite (PR Newswire)
24.04.18		Banco Santander Q1 Profit Rises YoY - Quick Facts (RTTNews)
12.04.18		Sanofi to invest €350 million in Canadian vaccine facility (PR Newswire)
12.04.18		Sanofi to invest €350 million in Canadian vaccine facility (PR Newswire)
12.04.18		New tools, support and information on insulin use now available to Canadians living with Type 2 diabetes aiming to maintain healthy blood glucose levels (PR Newswire)
12.04.18		New tools, support and information on insulin use now available to Canadians living with Type 2 diabetes aiming to maintain healthy blood glucose levels (PR Newswire)
05.04.18		New Sanofi insulin savings program aims to lower out-of-pocket costs for people living with diabetes (PR Newswire)
03.04.18		Santander Holdings USA declares quarterly dividend on preferred stock (PR Newswire)
28.03.18		The Georgetown University/Santander Social Economy Partnership Hosts Seminar On Financial Inclusion (PR Newswire)
27.03.18		FDA approves Toujeo® Max SoloStar® (PR Newswire)
26.03.18		Banco Santander: Popular Unit To Sell Stake In WiZink Bank - Quick Facts (RTTNews)
21.03.18		Santander Bank and Greater Providence Chamber of Commerce Host 18th Annual Economic Outlook Event for Rhode Island Business Leaders (PR Newswire)
21.03.18		Santander Bank Raises Its Prime Rate To 4.75% (PR Newswire)
10.03.18		Sanofi and Regeneron announce plans to make Praluent® more accessible and affordable for patients with the greatest health risk and unmet need (PR Newswire)
10.03.18		Praluent® (alirocumab) Injection significantly reduced risk of cardiovascular events in high-risk patients, and was associated with lower death rate (PR Newswire)
02.03.18		Advisory - Injectable products and unauthorized prescription drugs seized from Total Health Centre in Williams Lake, B.C.; products were being administered and sold by an individual posing as a... (PR Newswire)
19.02.18		Results from Innovative Phase 2 Tuberculosis Vaccine Trial Offer Potential for New BCG Revaccination Strategies, Hope For Subunit Vaccines (PR Newswire)
15.02.18		Santander Holdings USA, Inc. Announces Pricing Of Its Cash Tender Offer For Up To $400,000,000 In Aggregate Principal Amount Of Certain Senior Notes (PR Newswire)
15.02.18		Santander Holdings USA, Inc. Announces Early Participation Results For Its Cash Tender Offer For Up To $400,000,000 In Aggregate Principal Amount Of Certain Senior Notes (PR Newswire)
08.02.18		First targeted treatment for adults with moderate-to-severe atopic dermatitis, Dupixent™, now available in Canada (PR Newswire)
08.02.18		First targeted treatment for adults with moderate-to-severe atopic dermatitis, Dupixent™, now available in Canada (PR Newswire)
07.02.18		Sanofi Delivers 2017 Business EPS in line with Guidance (PR Newswire)
06.02.18		New Molecular Test to Impact Influenza Pandemic Preparedness (PR Newswire)

Zurück | 1 | 2 | Weiter

Newssuche

Meistgelesene Nachrichten

Krypto-Influencer prognostiziert für 2025 gewaltige Rally beim Dogecoin

Solana Kurs-Prognose: 300 US-Dollar noch im Januar?

Krypto-News: Während der Bitcoin konsolidiert pumpen Solana, Ripple und der Dogecoin

Hochstufung durch Exane BNP Paribas treibt UBS-Aktie an

Zinspolitik 2025: EZB plant Senkungen - wie schnell kommen sie?

Erfolgreiches Jahr: Volkswagen steigert US-Absatz der Marke VW

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2025 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	05.01.2025 10:18
Kaufwert:	EUR
	Hinzufügen Speichern